| Literature DB >> 29678961 |
Jeffrey Lambe1, Bernadette Monaghan1, Tudor Munteanu1, Janice Redmond1.
Abstract
Increasing availability of next-generation sequencing technologies has revealed several limitations of diagnosis-driven traditional clinicogenetic disease classifications, particularly among patients with an atypical or mixed phenotype. Hereditary spastic paraplegia (HSP) and spinocerebellar ataxia (SCA) are two such disease entities with an often overlapping presentation, in which next generation exome sequencing has played a key role in identification of genes causing disease along a continuum of ataxia and spasticity. We describe a patient who presented with features of both ataxia and spasticity, in whom initial diagnostic testing was inconclusive. Ultimately next generation exome sequencing identified homozygosity for a pathogenic variant in exon 13 of the CAPN1 gene c.1534C>T(p.Arg512Cys). This case supports consideration of a less discriminatory classification system among such patients, potentially allowing for more expedient diagnosis through testing of a larger gene panel along the 'ataxia-spasticity spectrum'. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: cerebellar ataxia; genetics; heredit spastic paraplegia
Mesh:
Substances:
Year: 2018 PMID: 29678961 DOI: 10.1136/practneurol-2017-001842
Source DB: PubMed Journal: Pract Neurol ISSN: 1474-7758